Search filters

List of works by Galina V Yamshchikov

A proof of concept for structure-based vaccine design targeting RSV in humans

scientific article published on 01 August 2019

An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

scientific article published in June 2017

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

scientific article

Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus

scientific article published in January 2014

Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses

scientific article published on 10 March 2017

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

scientific article

Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost

scientific article published on 11 August 2015

Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.

scientific article published on 24 January 2018

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

scientific article published on 14 August 2014

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

scientific article published on 4 December 2017

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

article by Martin R Gaudinski et al published 2 March 2019 in The Lancet

Paulina is supported by:

About Paulina

Help